Glenmark Pharmaceuticals submits media release

30 Aug 2019

Glenmark Pharmaceuticals has informed about submission of media release titled ‘Glenmark Pharmaceuticals receives ANDA approval for Pimecrolimus Cream, 1%’, which is self-explanatory. 

The above information is a part of company’s filings submitted to BSE.

Related Glenmark Pharmaceuticals Ltd. Links:

Glenmark Pharma Share Price

415.45 0.00 (0.00%) Jul 13, 18:01
1 Year Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 499.65
Dr. Reddys Lab 3898.60
Lupin 869.30
Piramal Enterprises 1432.20
Cadila Healthcare 358.20
View more..
Sensex vs Glenmark Pharma
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323
Research Analyst - INH000000719

Callback